Management and treatment of the HCV-infected kidney transplant patient.
Management and treatment of the HCV-infected kidney transplant patient.
Semin Dial. 2018 Dec 09;:
Authors: Wong T, Bloom RD
Abstract
The prevalence of hepatitis C virus infection is increased in patients with end stage kidney disease compared to the general population and is an adverse outcome determinant. Direct-acting antiviral therapy for hepatitis C virus is changing the management paradigm of infected kidney transplant candidates and recipients, with potential to reduce patient morbidity and mortality. This review describes the hepatic and nonhepatic manifestations of hepatitis C virus in kidney transplant patients as well as management and treatment strategies to optimize transplant outcomes, highlighting the importance of direct-acting antivirals in this population.
PMID: 30536995 [PubMed - as supplied by publisher]
Source: Seminars in Dialysis - Category: Urology & Nephrology Authors: Wong T, Bloom RD Tags: Semin Dial Source Type: research
More News: Antiviral Therapy | Dialysis | Hepatitis | Hepatitis C | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology